Government approves Bharat Biotech’s Nasal covid vaccine

Category : National Published on: December 26 2022

Share on facebook

The government of India on 23 December 2022 has allowed the use of Bharat Biotech's nasal COVID-19 vaccine as a booster dose. The vaccine will be offered to people of 18 years and above.
The vaccine will be available initially at the private hospitals and can be booked on the CoWIN app from 23 December 2022.
The nasal vaccine ‘BBV154’ had received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose.
It was developed in partnership with Washington University, St. Louis of the United States of America.
Hyderabad based Bharat Biotech company has also developed injectable Covaxin vaccine with Indian Council of Medical Research (ICMR) and National Institute of Virology, Pune.